Mumbai, March 3
Lupin Ltd has entered into an agreement with Chester Valley Pharmaceuticals in the US to promote Atopiclair non-steroidal cream to paediatricians.
The agreement was formalised through its wholly owned subsidiary, Lupin Pharmaceuticals Inc, a company communiqué said. Atopiclair non-steroidal cream is used in skin-related indications, to relieve symptoms of atopic dermatitis and allergic contact dermatitis.
As per the agreement, Lupin's paediatric sales force will promote Atopiclair cream. Lupin had created a dedicated paediatric sales force to promote its third generation cephalosporin, Suprax, also in the US.